Dapagliflozin Tablets 10 mg
Dapagliflozin 10mg
Tablet · Prescription medication
Samik Pharmaceutical Co., Ltd.
MFDS item code 202004454 · Approved 2020.06.17
This product's status changed to Expired on 2025.06.17. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used as an adjunct to dietary and exercise therapy to help control blood sugar levels in patients with type 2 diabetes. It can be administered alone or used in combination with other diabetes medications such as metformin, sulfonylureas, insulin, and sitagliptin when blood sugar control is difficult. Particularly, it is added when monotherapy is ineffective for patients who have not previously experienced diabetes medication treatment, or when blood sugar control is difficult with existing drug therapy. Thus, it helps improve blood sugar management through various combination therapies and monotherapies. Therefore, this medication effectively improves blood sugar control in patients with type 2 diabetes.
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medication is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this medication is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received pharmacological treatment for diabetes, when this medication is administered in combination with metformin, the recommended initial dose is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medication is not recommended for the purpose of improving glycemic control. - Patients on dialysis: Do not administer this medication. Hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, an initial dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medication may be administered orally once daily at any time of day, with or without food. The tablet should be swallowed whole.
Children The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.
This medication is not to be administered to patients with allergies to the active ingredients or excipients of this medication, as well as type 1 diabetes patients or those with diabetic ketoacidosis. Additionally, it contains anhydrous lactose, so it should not be used in patients with genetic disorders such as galactose intolerance, lactase deficiency, or glucose-galactose malabsorption. This medication is also contraindicated in patients undergoing renal dialysis. Caution should be exercised when using this medication in patients with reduced fluid volume or impaired kidney function. This medication may lower blood pressure or cause transient changes in kidney function, increasing the risk of hypotension or acute kidney injury. Particularly, patients with decreased kidney function, the elderly, or those on diuretics require extra caution, and fluid status and kidney function should be closely monitored before and during treatment. During the use of this medication, genital and urinary tract infections may occur. These are more common in women, and patients with a history of previous infections are at higher risk of recurrence, so immediate treatment is necessary if symptoms of infection appear. The risk of hypoglycemia may increase when taken with insulin or sulfonylureas, so caution for hypoglycemic symptoms and dosage adjustments are necessary when combining with these medications. Symptoms of dehydration or hypotension due to decreased fluid volume may occur, so particularly elderly patients or those taking diuretics should closely monitor fluid status. There is a risk of a serious metabolic condition known as diabetic ketoacidosis, so if symptoms of ketoacidosis appear, immediate testing and treatment must be sought, even if blood sugar is not very high. There have been reports of a rare but serious infection known as perineal necrotizing fasciitis, so if symptoms such as pain, redness, swelling, or ulceration occur around the perineum or genital area, immediate consultation with healthcare professionals is necessary. Pregnant or breastfeeding women are advised against using this medication and should discontinue use if pregnancy is confirmed. This medication does not significantly affect driving or operation of machinery; however, caution is needed when combined with medications that pose a hypoglycemic risk. During the use of this medication, regular monitoring of blood pressure, kidney function, blood sugar, and signs of infection should be conducted to ensure safe treatment.
Vulvitis, balantis, related genital infections, urinary tract infections, fungal infections, perineal necrosis, hypoglycemia, decreased fluid volume, thirst, diabetic ketoacidosis, dizziness, constipation, dry mouth, back pain, dysuria, polyuria, nocturia, interstitial nephritis, vulvar pruritus, genital pruritus, elevated hematocrit, decreased renal creatinine clearance, dyslipidemia, elevated blood creatinine, elevated blood urea, weight loss, ketosis, urosepsis, pyelonephritis, acute renal injury, renal dysfunction, rash, angioedema, asthenia, pain, keratitis, chronic obstructive pulmonary disease, hemoptysis, cerebral hemorrhage, peripheral artery occlusion, angina pectoris, myocardial infarction, choledocholithiasis, cholangitis, alcoholic cirrhosis, depression, suicide attempt, gastric adenocarcinoma, anaphylactic reaction, acute pyelonephritis, chest pain, chronic gastritis, diverticulosis, pneumatic perforation of the gastrointestinal tract, frequent bowel movements, gastroenteritis, colon polyps, intestinal perforation, epigastric discomfort, functional dyspepsia, erosive gastritis, gingival disorders, gingival pain, hemorrhoids, hiatal hernia, irritable bowel syndrome, black stools, chronic pancreatitis, urgency, diabetic nephropathy, overactive bladder, microalbuminuria, stress urinary incontinence, hesitancy, urinary stones, abnormal urination, increased blood lactate, lymphocytopenia, vitamin D deficiency, increased appetite, taste disturbance, drowsiness, tension headache, carpal tunnel syndrome, diabetic neuropathy, unconsciousness, neural compression, neuralgia, peripheral neuropathy, sleep disorders, syncope, tremor, bronchitis, herpes zoster, sinusitis, tonsillitis, diverticulitis, herpes simplex, chalazion, joint abscess, laryngitis, otitis media, pelvic inflammatory disease, periodontal abscess, pneumonia, pulmonary tuberculosis, rhinitis, onychomycosis, herpes simplex, edema, fever, foreign body sensation, facial swelling, facial pain, warmth, influenza-like symptoms, vaginal discharge, menstrual irregularities, pruritus, urticaria, cold sweats, arthralgia, musculoskeletal pain, limb pain, muscle weakness, myalgia, osteoarthritis, ligament sprain, diabetic retinopathy, cough, shortness of breath, orthostatic hypotension, palpitations, insomnia, fatty liver, gallbladder polyp, tinnitus
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it must be stored in a tightly closed container. It is advisable to maintain a storage temperature between 1 degree and 30 degrees Celsius to preserve the efficacy of the medication for a longer period.
Yellow, biconvex rhomboid film-coated tablets
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Dapagliflozin 10mg
Tablet · Prescription medication
Samik Pharmaceutical Co., Ltd.

Dapagliflozin 10mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Dapagliflozin 5mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Dapagliflozin 10mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Dapagliflozin 10mg
Tablet · Prescription medication
Korea Prime Pharma Co., Ltd.
Dapagliflozin 10mg
Tablet · Prescription medication
Withus Pharmaceutical Co., Ltd.
Dapagliflozin 10mg
Tablet · Prescription medication
IYUN Pharmaceutical Co., Ltd.
Dapagliflozin 10mg
Tablet · Prescription medication
Litepharmtech Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.